Related coverage linked through entity extraction aliases.
Jul 09, 2026
Biogen marked 30 years of U.S. manufacturing with a $2 billion RTP investment, while regional leaders urged deeper venture capital and research density to boost North Carolina's biotech competitiveness.
Feb 26, 2026
Four biotech companies went public in one week raising nearly $1 billion, signaling a potential thaw in IPO markets after years of quiet activity. Regional life sciences hubs outside Boston and San Francisco are attracting record venture funding, while regulatory uncertainty at FDA continues to concern industry leaders.
Feb 19, 2026
Ten63 Therapeutics announced strategic investment from Chugai Venture Fund and the Gates Foundation, bringing total funding to more than $45 million to advance its BEYOND AI drug discovery platform targeting previously undruggable proteins.
